CervoMed (CRVO) Depreciation & Amortization - Total (2015 - 2021)
CervoMed (CRVO) posted Depreciation & Amortization - Total of $26114.0 for Q4 2021, up 36.72% sequentially from $19100.0 in Q3 2021, and up 4.73% YoY from $24935.0 in Q4 2020.
CervoMed (CRVO) Depreciation & Amortization - Total (2015 - 2021) Analysis & Trends
CervoMed has reported Depreciation & Amortization - Total for 7 years, with the latest figure at $26114.0 in Q4 2021.
- Quarterly Depreciation & Amortization - Total rose 4.73% year-over-year to $26114.0 in Q4 2021, while the trailing twelve-month figure through Sep 2022 was $26114.0 (down 71.69% YoY) and the FY2021 annual result came in at $93416.0, down 9.45% from the prior year.
- Depreciation & Amortization - Total grew to $26114.0 in Q4 2021 per CRVO's latest filing, from $19100.0 in the prior quarter.
- Over five years, Depreciation & Amortization - Total peaked at $34390.0 in Q2 2019 and troughed at $5790.0 in Q2 2017.
- A 5-year average of $23642.6 and a median of $26411.5 in 2018 frame the typical range for Depreciation & Amortization - Total.
- The sharpest annual moves came in 2017 and 2019: Depreciation & Amortization - Total jumped 384.61% in 2017, then sank 34.78% in 2019.
- Over 5 years, Depreciation & Amortization - Total stood at $28214.0 in 2017, then advanced by 2.51% to $28921.0 in 2018, then slipped by 6.38% to $27075.0 in 2019, then slipped by 7.9% to $24935.0 in 2020, then gained by 4.73% to $26114.0 in 2021.
- According to Business Quant data, Depreciation & Amortization - Total over the past three periods registered $26114.0, $19100.0, and $23755.0 for Q4 2021, Q3 2021, and Q2 2021 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dep. & Amort. (Tot) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | CervoMed | 26.64 Mn | 26.64 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 26,114.00 |
| Sep 30, 2021 | 19,100.00 |
| Jun 30, 2021 | 23,755.00 |
| Mar 31, 2021 | 24,447.00 |
| Dec 31, 2020 | 24,935.00 |
| Sep 30, 2020 | 24,192.00 |
| Jun 30, 2020 | 27,021.00 |
| Mar 31, 2020 | 27,020.00 |
| Dec 31, 2019 | 27,075.00 |
| Sep 30, 2019 | 18,178.00 |
| Jun 30, 2019 | 34,390.00 |
| Mar 31, 2019 | 18,272.00 |
| Dec 31, 2018 | 28,921.00 |
| Sep 30, 2018 | 26,723.00 |
| Jun 30, 2018 | 26,709.00 |
| Mar 31, 2018 | 28,018.00 |
| Dec 31, 2017 | 28,214.00 |
| Sep 30, 2017 | 27,374.00 |
| Jun 30, 2017 | 5,790.00 |
| Mar 31, 2017 | 6,603.00 |